List of Excipients in API ganaxolone
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing ganaxolone
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Marinus Pharmaceuticals Inc | ZTALMY | ganaxolone | 81583-100 | ANHYDROUS CITRIC ACID | 2029-06-01 |
Marinus Pharmaceuticals Inc | ZTALMY | ganaxolone | 81583-100 | HYPROMELLOSE | 2029-06-01 |
Marinus Pharmaceuticals Inc | ZTALMY | ganaxolone | 81583-100 | METHYLPARABEN | 2029-06-01 |
Marinus Pharmaceuticals Inc | ZTALMY | ganaxolone | 81583-100 | POLYVINYL ALCOHOL | 2029-06-01 |
Marinus Pharmaceuticals Inc | ZTALMY | ganaxolone | 81583-100 | PROPYLPARABEN | 2029-06-01 |
Marinus Pharmaceuticals Inc | ZTALMY | ganaxolone | 81583-100 | SODIUM BENZOATE | 2029-06-01 |
Marinus Pharmaceuticals Inc | ZTALMY | ganaxolone | 81583-100 | SODIUM CITRATE | 2029-06-01 |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for ganaxolone
Excipient focus: ANHYDROUS CITRIC ACID
ganaxolone drug variants containing ANHYDROUS CITRIC ACID
Company | Ingredient | NDC |
---|---|---|
Marinus Pharmaceuticals Inc | ganaxolone | 81583-100 |
>Company | >Ingredient | >NDC |
ganaxolone drug variants not containing ANHYDROUS CITRIC ACID
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
ganaxolone drug variants containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Marinus Pharmaceuticals Inc | ganaxolone | 81583-100 |
>Company | >Ingredient | >NDC |
ganaxolone drug variants not containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
ganaxolone drug variants containing METHYLPARABEN
Company | Ingredient | NDC |
---|---|---|
Marinus Pharmaceuticals Inc | ganaxolone | 81583-100 |
>Company | >Ingredient | >NDC |
ganaxolone drug variants not containing METHYLPARABEN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
ganaxolone drug variants containing POLYVINYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Marinus Pharmaceuticals Inc | ganaxolone | 81583-100 |
>Company | >Ingredient | >NDC |
ganaxolone drug variants not containing POLYVINYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN
ganaxolone drug variants containing PROPYLPARABEN
Company | Ingredient | NDC |
---|---|---|
Marinus Pharmaceuticals Inc | ganaxolone | 81583-100 |
>Company | >Ingredient | >NDC |
ganaxolone drug variants not containing PROPYLPARABEN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM BENZOATE
ganaxolone drug variants containing SODIUM BENZOATE
Company | Ingredient | NDC |
---|---|---|
Marinus Pharmaceuticals Inc | ganaxolone | 81583-100 |
>Company | >Ingredient | >NDC |
ganaxolone drug variants not containing SODIUM BENZOATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM CITRATE
ganaxolone drug variants containing SODIUM CITRATE
Company | Ingredient | NDC |
---|---|---|
Marinus Pharmaceuticals Inc | ganaxolone | 81583-100 |
>Company | >Ingredient | >NDC |
ganaxolone drug variants not containing SODIUM CITRATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
ganaxolone drug variants containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
Marinus Pharmaceuticals Inc | ganaxolone | 81583-100 |
>Company | >Ingredient | >NDC |
ganaxolone drug variants not containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SUCRALOSE
ganaxolone drug variants containing SUCRALOSE
Company | Ingredient | NDC |
---|---|---|
Marinus Pharmaceuticals Inc | ganaxolone | 81583-100 |
>Company | >Ingredient | >NDC |
ganaxolone drug variants not containing SUCRALOSE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: WATER
ganaxolone drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
Marinus Pharmaceuticals Inc | ganaxolone | 81583-100 |
>Company | >Ingredient | >NDC |
ganaxolone drug variants not containing WATER
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.